tel: (646)-791-2397 info@synergycap1.com
  • Facebook
  • Twitter
  • Facebook
  • Twitter
Synergy Capital
  • Business Financing
  • Careers
  • Partner
  • Apply
  • About Us
  • Contact Us
  • Synergy Capital
  • News
Select Page

Credit conditions for most business lending unchanged in fourth quarter : Fed

by synergycap1 | Feb 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

WASHINGTON (Reuters) – Loan officers at U.S. banks reported largely unchanged lending standards and slightly looser terms for business loans in the last three months of 2016, the Federal Reserve reported on Monday in a quarterly survey.

Despite risks, public pensions put faith in long-term returns

by synergycap1 | Feb 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

SAN FRANCISCO (Reuters) – U.S. public pension funds are cutting their expectations for investment returns over the next 30 years or more, but some do not expect to meet even the new targets over the coming decade.

Pimco Total Return Fund posts Jan. cash withdrawals of $1.6 billion

by synergycap1 | Feb 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

NEW YORK (Reuters) – Investors pulled $1.6 billion from the Pimco Total Return Fund in January, leaving assets under management of $75 billion, Morningstar data showed on Monday.

Trump’s bonfire of banking rules could burn us all | Nils Pratley

by synergycap1 | Feb 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

“The last thing we want at this point in time is a relaxation of regulation,” said Mario Draghi, president of the European Central Bank on Monday. He is right to worry. Relaxation of financial regulation is exactly what Donald Trump has in mind and the...

Mylan agreed to pay $96.5 million in Provigil antitrust class action

by synergycap1 | Feb 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

Mylan has agreed to pay $96.5 million to settle claims by drug purchasers that it delayed launching a generic version of Cephalon’s narcolepsy drug Provigil in exchange for payment from Cephalon. The settlement was disclosed in a filing by the drug purchasers in...

Despite critics’ claims, Dodd-Frank hasn’t slowed lending

by synergycap1 | Feb 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

There may be good reasons to overhaul parts of the sweeping Dodd-Frank financial reforms, enacted in 2010 in response to the financial crisis two years earlier. But concern about a slowdown in bank lending isn’t one of them. President Donald Trump and...
« Older Entries
Next Entries »
Copyright © 2016 Synergy Capital. All rights reserved.